This collection contains guidelines, forms and documents related to accessing alglucosidase alfa (Myozyme®) and avalglucosidase alfa (Nexviazyme®) under the Life Saving Drugs Program for patients with:
- infantile-onset Pompe disease
- late-onset Pompe disease.
Click to view the product information for Myozyme® and Nexviazyme® on the Therapeutic Goods Administration website.
Medicines review documents
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.